PHAR Pharming Group N.V.

NASDAQ
$10.46

Pharming Group N.V. (PHAR) is expected to report earnings on October 30, 2026, before the market open. The consensus earnings estimate is $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.4% since its last earnings release on July 30, 2026.

Pharming Group N.V. Missed Consensus Estimates
Thursday, July 30, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 30
Friday · Before Open
Earnings Whisper
-
vs $0.10
Rev est $102.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $11.21

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Pharming Group N.V.

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.